BSE filing, NSE: SOMDUTTFIN. Summary written from the filing by ALFA Finder's alert engine.
Crescentis Capital Ltd: key numbers
- Share price
- ₹84.45
- Market cap
- ₹229.9 Cr
- Revenue (annual)
- ₹1.48 Cr
- Net profit (annual)
- ₹-2.53 Cr
- P/E (TTM)
- 195.2×Sector 20.3×
- Promoter holding
- 74.98%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Crescentis Capital Ltd
All →Crescentis Capital Fund Raise of ₹79.62 Cr
Crescentis Capital's board approved the Letter of Offer for a rights issue of 1,02,08,129 shares at Rs.78 each. The issue aggregates to Rs.7,962.34 lakhs, or about Rs.79.62 Crore, assuming full subscription.
- Value
- ₹79.62 Cr
- Execution
- Issue opening November 16, 2026; closing November 27, 2026; listing on or about December 3, 2026
Crescentis Capital Capital Structure Change
Crescentis Capital approved Rights Issue terms: 1,02,08,129 shares at ₹78, raising ₹79.62 Crore. Record date November 4; issue closes November 27, 2026.
- Value
- ₹79.62 Cr
Crescentis Capital Board Meeting Date
Crescentis Capital will hold a Fund-Raising Committee meeting on 29 October 2026 to approve the terms of a proposed rights issue of up to Rs 80 crore. The filing is a prior intimation of that committee meeting.
Crescentis Capital Other Announcement
Crescentis Capital Limited submitted the Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026, as per SEBI regulations.
Crescentis Capital Other Announcement
Crescentis Capital Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Crescentis Capital Employee Stock Options
Crescentis Capital Limited granted 5,00,000 stock options to its Managing Director, Mr. Subba Rao Veeravenkata Meka, under the company's 2025 ESOS scheme.
Other board meeting date announcements
All →Lovable Lingerie Board Meeting Date
Lovable Lingerie will hold a board meeting on 14 November 2026 to consider unaudited quarterly results for September 2026. Trading window is closed from 1 October 2026 until 16 November 2026.
DPSC Board Meeting Date
DPSC Limited will hold a board meeting on 13 November 2026 to approve unaudited half-yearly results. Trading window closes from 1 October until 15 November 2026.
PTC Industries Board Meeting Date
PTC Industries intimated a board meeting on 14 November 2026 to consider unaudited standalone and consolidated half-yearly financial results for the period ended September 2026. The trading window is closed from 1 October to 16 November 2026.
Godavari Drugs Board Meeting Date
Godavari Drugs will hold a board meeting on 11 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after the results are declared.
Beryl Drugs Board Meeting Date
Beryl Drugs Ltd has notified a board meeting on 14 November 2026 to consider unaudited results for the quarter ended 30 September 2026 and the limited review report. The trading window stays closed until 48 hours after the meeting.
Prime Focus Board Meeting Date
Prime Focus has scheduled a board meeting on 13 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window remains closed until 48 hours after results.